Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001730145-25-000035·ACTUATE THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Actuate Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 005083100
Event date: 2025-12-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Voss Capital, LP
Shares: 1,227,756.00 · Class: 5.3%
- Cocke Travis W.
Shares: 1,227,756.00 · Class: 5.3%
- Voss Advisors GP, LLC
Shares: 250,000.00 · Class: 1.1%
- Voss Value Master Fund, LP
Shares: 200,000.00 · Class: 0.9%
- Voss Value-Oriented Special Situations Fund, LP
Shares: 50,000.00 · Class: 0.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001730145-25-000035
- Form type
- SCHEDULE 13G
- Filer
- ACTUATE THERAPEUTICS, INC.
- CIK
- CIK 1652935
- Filed
- Dec 17, 2025
- Reporting period
- Dec 15, 2025
- Description
- Schedule 13G beneficial ownership